Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Brain tumor Stories

2013-11-21 23:24:23

Funding supports development of two new malignant glioma drugs. Chicago, IL (PRWEB) November 21, 2013 In just three years since the American Brain Tumor Association (ABTA) launched its Discovery Grant program, the organization is pleased to announce that its funding has aided the development of two new brain tumor drugs that target malignant gliomas such as glioblastoma multiforme (GBM)—a common and aggressive type of malignant brain tumor. While meeting with leading scientists and...

2013-11-19 12:29:24

HAIFA, Israel, Nov. 19, 2013 /PRNewswire/ -- Novocure announced today that the first patients have enrolled in the EF-21 Study, a prospective randomized clinical study of NovoTTF(TM) Therapy for patients with brain metastases from non-small cell lung carcinoma (NSCLC) cancer. NovoTTF Therapy is an anti-mitotic treatment delivered continuously throughout the day by the NovoTTF-100A System. "The EF-21 Study builds on extensive preclinical research on the effect of NovoTTF Therapy in...

2013-11-18 08:30:09

Neuro-Oncology experts from around the world will gather in San Francisco where data supporting the role of Tumor Treating Fields (TTFields) in treating recurrent glioblastoma brain tumors will be presented ST. HELIER, Jersey, Nov. 18, 2013 /PRNewswire/ -- Novocure announced today that 15 preclinical and clinical abstracts describing the latest aspects of NovoTTF(TM) Therapy will be presented at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO), which is...

2013-11-15 23:24:24

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a new protein that kills tumor stem cells. New York, NY (PRWEB) November 15, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a new protein that may become a vital factor in future brain cancer treatments. According to an October 18th, 2013 article published by the Deccan Chronicle titled “Scientist finds new protein to...

2013-11-14 08:33:50

VANCOUVER, British Columbia and MENLO PARK, Calif., Nov. 14, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced that the Company will present interim clinical trial data for VAL-083 in glioblastoma at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18(th) Annual Society for Neuro-Oncology (SNO) meeting. The WFNO/SNO meeting will take place November 21(st)...

2013-11-12 16:26:46

ROCKVILLE, Md., Nov. 12, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported financial results for the three months and nine months ended September 30, 2013 and provided a business and clinical update. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) "The Company reached several major milestones in the third quarter. We completed patient dosing in our Phase Ib trial to treat major depressive disorder with NSI-189, our lead small molecule compound....

2013-11-12 09:13:31

Also reports on trial of new brain cancer vaccine; brain stimulation causes 'foreign accent syndrome' Hospitals vary in management of children with traumatic brain injury—particularly in monitoring and preventing the harmful effects of increased intracranial pressure (ICP), according to a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health....

2013-11-11 16:23:35

More than 80 surgeons now CME trained on BrainPath; 400 cases completed INDIANAPOLIS, Nov. 11, 2013 /PRNewswire/ -- Indianapolis medical device maker NICO Corporation has added to its recently introduced BrainPath product line with the BrainPath ST-Gold, a tool clinically essential for accessing surface brain abnormalities. The NICO BrainPath provides a unique surgical access system allowing visualization of abnormalities in the subcortical space and dramatically changing how...

2013-11-11 08:27:57

MELBOURNE, Australia and HAMBURG, Germany, Nov. 11, 2013 /PRNewswire/ -- -- Novel drug which improves visualisation and resection of malignant brain tumours now widely available -- Twice as many patients are without progression of brain cancer six months after surgery with GLIOLAN -- To date over 100 Australian patients have been treated with GLIOLAN via the Federal Government's Special Access Scheme A novel drug which assists neurosurgeons to better...

2013-11-11 04:21:07

-Study Features THC and CBD as the Primary Cannabinoids- LONDON, Nov. 11, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW") a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today it has commenced a Phase 1b/2a clinical trial for the treatment of Recurrent Glioblastoma Multiforme (GBM). Glioma describes any tumor that arises from the glial tissue...